🇺🇸 FDA
Patent

US 6586392

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

expired A61KA61K38/164A61K47/645

Quick answer

US patent 6586392 (Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/164, A61K47/645, A61K47/6817, A61P